BIOACTIVITY-GUIDED FRACTIONATION
    OF SELECTED BOTANICALS


          11th International Conference
           on the Science of Botanicals
                 Oxford, MS
               April 16-19, 2012

          A. Douglas Kinghorn1, Jie Li1,
     Hee-Byung Chai1, and William J. Keller2
      1College of Pharmacy, The Ohio State

        University and 2Nature’s Sunshine
                   Products, Inc.
MR. JIE LI                        DR. HEE-BYUNG CHAI
THE OHIO STATE                         THE OHIO STATE
  UNIVERSITY                             UNIVERSITY




                   DR. WILLIAM J.
                       KELLER
                 NATURE’S SUNSHINE
                  PRODUCTS, INC.
OUTLINE OF PRESENTATION

 Reminiscences of the Late Norm Farnsworth as
  a Mentor and Colleague.

 Application of “Activity-guided Fractionation”
  to Furnish Potential Cancer Chemopreventive
  Principles of Several Botanicals: Black
  Chokeberry (Aronia melanocarpa),        Maqui
  Berry (Aristotelia chilensis), Mangosteen
  (Garcinia mangostana), and Noni (Morinda
  citrifolia).
Late Dr. Norman R.
     Farnsworth
University of Illinois at
       Chicago
      1930-2011

 (Fong et al., J. Nat.
 Prod. 69, 311, 2006)
SCHOOL OF PHARMACY, UNIVERSITY OF
 LONDON (THE “SQUARE”; NOW UCL)


     PROFESSOR
      JAMES W.
     FAIRBAIRN
       (“PROF”)




     PROFESSOR
    FRED J. EVANS


                      PROFESSOR J. DAVID
                         PHILLIPSON
Bioactivity-guided Fractionation of Selected Botanticals
THE BEST DEPARTMENT OF PHARMACOGNOSY
AND PHARMACOLOGY IN THE WORLD, CA. 1977




   Shown are the faculty, staff, postdoctorals, and graduate students
National Cooperative Drug Discovery Group (NCDDG) (Ohio State, UIC, Research
  Triangle Institute, Bristol-Myers Squibb, National Cancer Institute) , circa 2005
CANCER CHEMOPREVENTION
A strategy of cancer control by administration of synthetic or natural
     compounds to reverse or suppress the process of carcinogenesis
                  (Sporn et al., Fed. Proc., 35, 1332, 1976)
SOME PROMISING PLANT-DERIVED COMPOUNDS UNDER
    DEVELOPMENT BY THE UNITED STATES NATIONAL CANCER INSTITUTE
             AS POTENTIAL CANCER CHEMOPREVENTIVES


Agent(s)                       Phase            Target Cancer(s)

Curcumin                       I/II/III         Colon; Pancreatic
Genistein                      II               Bladder; Breast; Kidney; Prostate; Skin
Indole-3-carbinol              I/II/III         Breast; Prostate
Perillyl alcohol               I/II             Breast; Leukemia; Pancreatic; Prostate
Soy isoflavones                II/III           Breast; Prostate
Tea (green)                    I/II             Bladder; Esophageal; Cervical; Leukemia;
                                                Liver; Lung; Prostate
Tea/epigallocatechin           I                Prostate
Resveratrol                    I/II             Colon; Solid cancers
Vitamin C                      II               Cervical; Ovarian; Uterine
Silibinin                      II                Prostate

                   (http://www.clinicaltrials.gov; accessed April, 2008)
MAJOR STAGES IN NATURAL PRODUCT
            DRUG DISCOVERY
 Organism collection (after development of intellectual property
 agreements).
 Preparation of extracts (using standardized extraction scheme).
 Initial bioassays (cell-based and target-based).
 Biostatistics; data management; dereplication of leads; lead
 prioritization).
 Bioactivity-directed fractionation (= isolation of active compounds from
 biomass using a decision tree based solely on bioactivity).
 Structure elucidation of bioactive compounds.
 Scale up and analog development of lead compounds.
 Advanced bioassays; data management; biostatistics.
 Lead optimization; pharmaceutical development.

(Clark, In Foye’s Principles of Medicinal Chemisry, 5th Edn., Williams, D.A.;
Lemke, T.L., Eds., Lippincott Williams & Wilkins: Baltimore, 2002, p. 24)
TYPES OF ASSAYS USED FOR POTENTIAL NATURAL PRODUCT
              CANCER CHEMOPREVENTIVE AGENTS

     SHORT-TERM IN VITRO BIOASSAYS BASED ON FACTORS
      ASSOCIATED WITH TUMOR INITIATION, PROMOTION AND
      PROGRESSION           Antimutagenicity
          Tumor Initiation: Antioxidant acitivity
                            Phase II enzyme induction (quinone
                            reductase induction)

                                 Antioxidant activity
          Tumor Promotion:       Cyclooxygenase inhibition
                                 Aromatase inhibition
                                 Ornithine decarboxylase inhibition
                                 Aromatase inhibition
          Tumor Progression:     Antiestrogenic activity
                                 Receptor assays with luciferase
                                 Differentiation-inducing agents
       (Modified from Pezzuto et al., In Cancer Chemoprevention, Vol. 2:
    Strategies for Cancer Chemoprevention, G. Kelloff et al., eds., Humana
                      Press, Inc., Totowa, NJ, 2005; p. 3)
BLACK CHOKEBERRY
      (ARONIA MELANOCARPA) (ROSACEAE)
 A deciduous shrub originating from the eastern parts of
  North America and East Canada, which has been introduced
  to Europe.
 Has a long tradition of use in European and North American
  folk medicine. Now used for the production of jam, juice,
  tea, wine, and as a natural colorant.
 Consumed in part because of its high antioxidant capacity
  when compared to other berries and fruits.



  (Kulling    et al.,       Planta
  Med., 74, 1625, 2008;
  Valcheva-Kuzmanova            et
  al., Folia Med., 48, 11, 2006)     www.vitarroz.com   www.seedman.com/fruit.htm
BIOLOGICAL ACTIVITIES OF BLACK
    CHOKEBERRY CONSTITUENTS OR EXTRACTS
 Antioxidant activities (phenolics)
 Chemopreventive      potential   via    antimutagenic    activity,
  immunomodulatory activity, and inhibition of carcinogenesis and
  cancer cell proliferation (flavonoid-rich fruit extract, isolated
  anthocyanins)
 Anti-inflammatory activities in vitro and in rats (fruit extract or
  juice)
 Miscellaneous:       hepatoprotective,   gastroprotective,     and
  cardioprotective effects; antibacterial and antiviral effects; and
  antidiabetic effects
Key references:
(Oszmianski et al., Eur. Food Res. Technol., 221, 809, 2005; Sueiro et al., J. Food Sci.,
71, C480, 2006; Ding et al., J. Biol. Chem., 281, 17359, 2006; Zapolska-Downar et
al., Eur. J. Nutr., DOI: 10.1007/s00394-011-0240-1; Borissova et al., Acta Physiol.
Pharmacol. Bulg., 20, 25, 1994; Valcheva-Kuzmanova et al., Exp. Toxicol. Pathol.,
56, 195, 2004; Simeonov et al., Folia Med., 44, 20, 2002)
HYDROXYL RADICAL-SCAVENGING AND QUINONE REDUCTASE
  INDUCTION ACTIVITIES OF ISOLATES OF BLACK CHOKEBERRY FRUITS
 From the results obtained, the following four isolates (hyperoside, 1;
  neochlorogenic acid methyl ester, 4; quercetin, 9; protocatechuic acid, 14)
  showed potent activities in the .OH-scavenging and QR induction assays:
MAQUI BERRY
 (ARISTOTELIA CHILENSIS) (ELAEOCARPACEAE)
 A native South America evergreen
  shrub.
 This species produces small edible
  purple or black berries that are eaten
  fresh or used for juice, jams, and wine-
  making.
                                                             www.healthytastychow.com
 The leaves and fruits are astringent and
  have been used in Chilean folk
  medicine as anti-diarrheal, anti-
  inflammatory, antihamorrhagic, and as
  a febrifuge.
  (Schreckinger et al., J. Med. Food, 13, 233, 2010;
  Escribano-Bailon        et    al., www.vitarroz.com
                                        Phytochem.      www.seedman.com/fruit.htm
                                                                    http://superberries.co.uk
  Anal., 17, 8, 2006)
BIOLOGICAL ACTIVITIES OF MAQUI
          BERRY CONSTITUENTS OR EXTRACTS
 Antioxidant activities (fruit extract or juice, phenolic
  extract, and 3-hydroxyindole derivatives)
 Chemopreventive effects and induction of apoptosis in
  cancer cell lines (cyanidin 3-O-glucoside, delphinidin 3-O-
  glucoside and other anthocyanins, and gallic acid)
 Anti-inflammatory activities (leaf extract)
 Miscellaneous:        analgesic, cardioprotective,                             α-
  glucosidase/α-amylase inhibitory, nematicidal,                                and
  antiviral activities.
Key references:
(Cespedes et al., Food Chem., 107, 820, 2008; Cespedes et al., Z. Naturforsch.,
64c, 759, 2009; Munoz et al., J. Pharm. Pharmacol., 63, 849, 2011; Rubilar et al., J.
Agric. Food Chem., 59, 1630, 2011; Schreckinger et al., J. Med. Food, 13, 233,
2010; Ohno et al., Anti-cancer Drugs, 10, 845, 1999; Hou et al., Curr. Mol. Med., 3,
149, 2003)
HYDROXYL RADICAL-SCAVENGING AND QUINONE REDUCTASE
         INDUCTION ACTIVITIES OF ISOLATES OF MAQUI BERRY
 From the results obtained, twelve compounds (1-12) showed potent antioxidant
  activity in the .OH-scavenging assay. Five compounds (3, 7, 9, 11, and 14) exhibited
  relatively high QR-inducing activity. Compounds 3 (gallic acid methyl ester), 9
  (protocatechuic acid), 7 (hyperoside), and 11 (guaijaverin) are shown below:
GARCINIA MANGOSTANA L. (MANGOSTEEN)
                (CLUSIACEAE)
 Garcinia mangostana L.
  (Clusiaceae),    commonly
  known as “Mangosteen”, is
  one of the most widely
  recognized tropical fruits.
 Known as the “queen of
  fruits”   and   used     in
  Southeast Asian traditional
  medicine.
 In Thai folk medicine, the
  pericarp of Mangosteen
  has been used for many
  years to healing skin
  infections and wounds and
  for relief of diarrhea.
MANGOSTEEN AS A BOTANICAL
         DIETARY SUPPLEMENT

 Now one of top-selling botanical dietary
  supplements in the U.S., sales of over $200
  million     in  2008   (Sloan,    Nutraceutical
  World, 13, 16, 2010).
 Mangosteen is used as a constituent of products
  sold in the United States for its antioxidant
  effects.
 Botanical products are standardized against α-
  mangostin (ca. 1% w/w yield from pericarps)
  and -mangostin (ca. 0.25% w/w yield from
  pericarps).
 Quite large amounts of the xanthone α-
  mangostin may be ingested in mangosteen juice.
CHEMICAL CONSTITUENT PROFILE OF GARCINIA
                 MANGOSTANA
 The following compound classes have been
reported to occur in various plant parts of
mangosteen, as published by the end of 2007:
  Xanthones                                                    68

  Flavonoids                                                   5

  Benzophenones                                                3

  Triterpenoids and Sterols                                    7

  Miscellaneous                                                3


     (Chin and Kinghorn, Mini-Rev. Org. Chem., 5, 355, 2008)
SUMMARY OF BIOLOGICAL ACTIVITIES OF MANGOSTEEN
           CONSTITUENTS/EXTRACTS
   Antioxidant (especially potent are -mangostin and -mangostin)
   Infectious disease related
        Antibacterial
        Antifungal
        Antimalarial
        HIV-protease and reverse transcriptase inhibition
   Cancer related
        Aromatase inhibition (-mangostin is active in both a
        microsomal and a cell-based assay)
        Cytotoxicity for cancer cells
        Inhibition of sphingomyelinase
        Inhibition of topoisomerases
        In vivo cancer chemoprevention
   Inflammation related
        Inhibition of COX, iNOS, IKK; in vivo carageenan-induced
        paw
   Miscellaneous
        Ca2+ATP-ase inhibitor
        H1-receptor antagonist
            (Balunas et al., J. Nat. Prod., 71, 1161, 2008; Chin and Kinghorn, Mini-Rev. Org.
                                    Chem., 5, 355, 2008)
XANTHONES ISOLATED FROM THE PERICARP OF
             MANGOSTEEN
PEROXYNITRITE ANTIOXIDANT ACTIVITY OF
           ISOLATED XANTHONES
                                                        IC50 (M)a
           Compound
                                     Authentic ONOO          SIN-1 derived ONOO
            1* (new)                          4.6                       10.0
      3 (smeathxanthone)                      2.2                       9.7
         4 (-mangostin)                     12.2                       <0.5
         5 (-mangostin)                      8.0                       3.1
      6 (8-deoxygartanin)                    N.A.c                      11.9
           7 (gartanin)                       9.1                       9.3
       8 (mangostinone)                      N.A.                       N.A.
        9 (tovophyllin A)                    N.A.                       N.A.
     10 (cudraxanthone G)                    N.A.                       3.2
         DL-penicillamineb                    3.1                       7.4
aONOO     is the scavenging activity of authentic peroxynitrite and generated
peroxynitrite from SIN-1 (IC50: M). Values of ONOO scavenging/inhibitory activities
expressed as the mean of three experiments. bDL-Penicillamine used as positive control.
cN.A.: no activity within the tested concentration (5-100 M).


                (Jung et al., J. Agric. Food Chem., 54, 2077, 2006)
PHARMACOKINETICS OF PURE -MANGOSTIN
       AFTER INTRAVENOUS ADMINISTRATION

                                            Parameters              Mean     SE
                                            C0 (ng/ml)              17880   4432
                                            Ke (1/hr)               0.26    0.03
                                            t1/2 (hr)               2.97    0.38
                                            AUC0-6 (ng*hr/ml)       1233    157.1
                                            AUC0-∞ (ng*hr/ml)       1372    140.4

Pharmacokinetic    parameters      were     AUMC0-6 (ng*hr*hr/ml)   791.3   63.84
determined after a single intravenous
dose of 2 mg/kg -mangostin in rats (n =    AUMC0-∞ (ng*hr*hr/ml)   2335    434.2
8), with data calculated using non-
compartmental analysis. Disposition
                                            MRT (hr)                1.85    0.39
biphasic     (fast distribution;   slow     Vz (L/kg)               6.82    1.10
elimination)..
                                            CL (L/hr/kg)            1.54    0.12
(Li et al., Mol. Nutr. Food Res. 55, S67,
2011)
PHARMACOKINETICS OF PURE -MANGOSTIN
        AFTER ORAL ADMINISTRATION




 On oral administration of a single dose of 20 mg/kg -mangostin to
  rats, the bioavailability was so low (ca. 0.4%) that it was not
  possible to obtain a full concentration-time profile.
 As a result of this study, it was concluded that it is questionable if
  the in vitro effects of -mangostin occur in an in vivo setting.
              (Li et al., Mol. Nutr. Food Res. 55, S67, 2011)
DETERMINATION OF BIOAVAILABILITY IN HUMANS
      OF XANTHONES FROM MANGOSTEEN JUICE
 The bioavailability of mangosteen xanthones using human
  subjects has received comparatively little attention.
 In a preliminary study, Kondo et al. administered ca. 60 mL
  of a supplement (mangosteen; aloe vera; green tea;
  multivitamins) to 20 fasted healthy human volunteers, and
  it was concluded that -mangostin is bioavailable
  (observed Cmax at tmax of ca. 1 hour) (Kondo et al. J. Agric.
  Food Chem., 57, 8788, 2009).
 In a study carried out at The Ohio State University, the
  bioavailability of xanthones was investigated in ten healthy
  adults (five females; five males), who consumed a single
  dose of 100% mangosteen juice along with a typical fast-
  food (high-fat) breakfast, which was supplemented with
  canola oil and soybean oil (Chitchumroonchokchai et al. J.
  Nutr., 142, 675, 2012).
PROFILE OF XANTHONE CONTENT IN THE
       MANGOSTEEN JUICE USED IN THE STUDY
 When analyzed by                                         Content       Percentage of
                                  Xanthones                in juice     total xanthones
  HPLC, the 100%                                            (µM)         identified (%)
  mangosteen juice                garcinone C             291 + 11.2           5.5

  used in the study               garcinone D             520 + 10.9          10.2
                                  garcinone E             239 + 18.5           5.1
  provided 5.3 + 0.1
                                 α-mangostin             3190 + 123           59.9
  mM            total            β-mangostin              121 + 9.3            2.3
  xanthones, with α-              -mangostin             356 + 4.3            6.5
  mangostin    being            8-deoxygartanin           176 + 4.5            3.1
  the most abundant                gartanin               157 + 6.9            2.8
                                 tovophillin B             50 + 2.9            1.1
  (59.9%),         as
                            9-hydroxycalabaxanthone       193 + 7.4            3.6
  indicated in the                   Totals              5290 + 166            100
  table.                         Values are means + SD; n = 5 independent replicates


         (Chitchumroonchokchai et al., J. Nutr., 142, 675, 2012)
PHARMACOKINETIC PARAMETERS OF FREE AND
        CONJUGATED α-MANGOSTIN IN SERUM
 There was marked variation         Participant   AUC (nM/L x h) Cmax (nM/L)   Tmax (h)

  in values of AUC (area under        Females

  the curve, 762-4029 nM x h),           1             1605           78           3

  Cmax               (maximum            2             962            57           8

  concentration, 42-450 nM),             3             4029          450           3
                                         4             1484          132           2
  and Tmax (time to the
                                         5             1249           79           3
  maximum concentration, 2-8
                                      Mean + SD    1870 + 1230     159 + 165    3.8 + 2.4
  h) for α-mangostin in the
                                       Males
  serum, during the 24-h
                                         1             1004           42           2
  collection period.
                                         2             771            44           8
 The serum AUC, Cmax, and               3             1798          154           4
  Tmax values of α-mangostin             4             816            42           2
  were similar in female and             5             762            49           2
  male participants.                  Mean + SD     1030 + 440      66 + 49     3.6 + 2.6


            (Chitchumroonchokchai et al., J. Nutr., 142, 675, 2012)
CONCLUSIONS FROM THE OHIO STATE BIOAVAILABILITY
    STUDY ON XANTHONES FROM MANGOSTEEN JUICE
 Both free and conjugated (glucuronidated/sulfated) xanthones
  were detected in serum and urine of healthy adult participants.
 There was marked variation in the AUC, Cmax, and Tmax for α-
  mangostin in serum samples during the 24-h collection period.
 The total xanthones in the 24-h urine samples ranged from 0.9-
  11.2 μM and accounted for ca. 2.0 ± 0.3% (range 0.3-3.4%) of the
  ingested dose of mangosteen juice.
 There were no significant differences between female and male
  participants in mean pharmacokinetic values of α-mangostin in
  serum and urinary total xanthones.
 Xanthones in mangosteen juice were absorbed when ingested
  along with a high fat meal, although the release of xanthones
  from the juice during digestion may be somewhat limited.
           (Chitchumroonchokchai et al., J. Nutr., 142, 675, 2012)
NONI (MORINDA CITRIFOLIA L.)
                             (RUBIACEAE)
   Occurs in tropical and
    subtropical      regions




                                                                           http://www.nps.gov/kaho/KAHOckLs/KAHOplnt/noni.htm
   Small evergreen tree or
    shrub
   Flowers perfect with five-
    lobed,      small       white
    corollas
   5 to 10 cm long fleshy,
    syncarpous fruit
   Unpleasant      taste    and
    butyric acid odor when
    ripe
   All parts (fruit, leaf, bark,
    flower, and seed) have
    been used medicinally
   Roots and bark are used
    as a dye
              (Pawlus and Kinghorn, J. Pharm. Pharmacol. 59, 1587, 2007)
CHEMICAL CONSTITUENT PROFILE OF MORINDA
                   CITRIFOLIA
The following compound classes have been reported
to occur in various plant parts of noni, with effect
from mid-2007:
    Anthraquinones                                               45

    Flavonoids                                                   10

    Iridoids                                                     18

    Lignans                                                      11

    Triterpenoids and Sterols                                    12

    Miscellaneous                                                >38

    (Pawlus and Kinghorn, J. Pharm. Pharmacol. 59, 1587, 2007)
QUINONE REDUCTASE-INDUCING ACTIVITY OF ISOLATED
                    CONSTITUENTS OF NONI FRUITS

      Compound           CDa, M (g/mL)        IC50b, M (g/mL)           CIc
          1d               0.009 (0.0027)          >69.9 (>20)             >7770
          2                 1.67 (0.52)            >66.6 (>20)             >39.9
   L-sulforaphane*          0.34 (0.061)           9.77 (1.73)              28.7

aCD  = Concentration required to double quinone reductase induction. bIC50 = Concentration
for 50% inhibition of cell viability. cCI = Chemopreventive Index. d Only 2 mg of 1,3,6-
trihydroxy-2-methoxyanthraquinone(1) isolated from ca. 9 kg dried noni fruits. * = Control.




                      1 (new)                                    2
                 (Pawlus et al., J. Nat. Prod. 68, 1720, 2005)
INHIBITORY EFFECT OF NONI FRUITS ON RAT
          ESOPHAGEAL TUMORIGENESIS
    Male F344 rats were fed a diet of 5% w/w dried
     powdered fruits of M. citrifolia (noni), and six other dried
     fruits, including black raspberry (Rubus occidentalis), in a
     comparison study.
    The        standard       carcinogen,       NMBA         (N-
     nitrosomethylbenzylamine was used to treat rats for five
     weeks, and the experiment was terminated after 35
     weeks.
    All seven fruits had similar effects on reducing
     esophageal tumor incidence, size, and multiplicity, and
     also reduced the levels of two serum cytokines.
    Noni fruits have lower levels of anthocyanins and
     ellagitannins than black raspberries.
            (Stoner et al., Pharm. Res. 27, 1138, 2010)
SEARCH FOR BIOLOGICALLY ACTIVE PRINCIPLES OF
    BOTANICAL DIETARY SUPPLEMENTS: SUMMARY

Botanical dietary supplements have become widely available in
the United States since the passage of the Dietary Supplement
Health and Education Act (DSHEA) in 1994. Their widespread
use has had a major impact on biomedical research and
pharmacy practice.
Fractionation studies on selected “botanicals” have yielded quite
potent biologically active compounds, although generally
occurring at low concentrations. Some of these are useful leads as
potential cancer chemopreventive agents.
The fruits of mangosteen (G. mangostana) and noni (M. citrifolia)
have already yielded interesting bioactive compounds. The
constituents of these botanical dietary supplements seem to offer
particular promise for further investigation.
ACKNOWLEDGMENTS

Phytochemical Studies                    Biological Testing
The Ohio State University               The Ohio State University
Dr. Young-Won Chin                      Dr. Marcy P. Balunas
Dr. Ye Deng                             Dr. Young-Won Chin
Dr. Hyun-Ah Jung                        Ms.     Chureeporn     Chitchumroonchokchai
                                        (Human Nutrition)
Dr. Alison D. Pawlus                    Dr. Alison D. Pawlus (at University of Illinois at
Dr. Baoning Su                          Chicago)
                                        Dr. Bin Su (Dr. Robert W. Brueggermeier)
Collaborators – The Ohio                Collaborator – University
State University                        of Florida
Dr. Steven Clinton                      Dr. Veronika Butterweck
Dr. Mark Falia                          Supply of Botanicals
Dr. Gary D. Stoner                      Nature’s  Sunshine           Products,       Inc.,
                                        Spanish Fork, Utah
    Faculty start-up funding from the Molecular Carcinogenesis and
 Chemoprevention Program of The Ohio State University Comprehensive
 Cancer Center (to A.D. Kinghorn), and an unrestricted gift from Nature’s
         Sunshine Products, Inc. are gratefully acknowledged.
THE PRESCIENT DR. FARNSWORTH!
College of Pharmacy and
OSU Comprehensive Cancer Center

More Related Content

PPTX
Bio assay guided isolation identification active constituents of walnut leav...
PPTX
Role of natural product in drug discovery
PPTX
Natural products in drug discovery
PDF
herb-drugherb-foodinteractions-200301152636.pdf
PPTX
Biosensors
PPTX
DRUG DESIGN AND DISCOVERY
PPT
History of drug discovery
PPTX
Health benefit & role of Neutraceuticals in ailments
Bio assay guided isolation identification active constituents of walnut leav...
Role of natural product in drug discovery
Natural products in drug discovery
herb-drugherb-foodinteractions-200301152636.pdf
Biosensors
DRUG DESIGN AND DISCOVERY
History of drug discovery
Health benefit & role of Neutraceuticals in ailments

What's hot (20)

PPTX
Nutraceuticals
PPTX
presentation on in silico studies
PPTX
Bioassay guided fractionation
PDF
AI for drug discovery
PPTX
Curent good agri. practices,prn
PDF
Biosensor ppt
PPTX
Traditional and Rational Drug Designing
PDF
Protein engineering
PPTX
Plant extraction and fractionation
PPTX
Drug discovery and development
PPTX
Nutraceuticals – let food be your medicine
PPTX
Natural product based drug discovery and SAR studies
PPTX
Biopharmaceuticals
PPTX
Nutraceuticals
PPTX
Recent advances in marine drugs
PPTX
ANTI - INFLAMMATORY ACTIVITY OF LEAVES OF JATROPHA GOSSYPIFOLIA L.
PPT
drug discovery & development
PPTX
Drug design
PPT
Drug design and discovery ppt
Nutraceuticals
presentation on in silico studies
Bioassay guided fractionation
AI for drug discovery
Curent good agri. practices,prn
Biosensor ppt
Traditional and Rational Drug Designing
Protein engineering
Plant extraction and fractionation
Drug discovery and development
Nutraceuticals – let food be your medicine
Natural product based drug discovery and SAR studies
Biopharmaceuticals
Nutraceuticals
Recent advances in marine drugs
ANTI - INFLAMMATORY ACTIVITY OF LEAVES OF JATROPHA GOSSYPIFOLIA L.
drug discovery & development
Drug design
Drug design and discovery ppt
Ad

Viewers also liked (12)

PDF
K based-chromatography: future and potential of Countercurrent Chromatography
PPTX
Richin final ppt 19
PDF
ANTIMICROBIAL ACTIVITY OF VARIOUS PLANTS EXTRACTS
PPTX
Chapter 22.2 : Radioactive Decay
PPTX
Antimicrobials ppt copy
PPT
Gene therapy - a Powerpoint Presentation
PPTX
Gene therapy
PPTX
Thin layer chromatography
PPT
Gene therapy
PPTX
RNA- Structure, Types and Functions
PPTX
Gene therapy ppt
PPT
Drug Development Life Cycle
K based-chromatography: future and potential of Countercurrent Chromatography
Richin final ppt 19
ANTIMICROBIAL ACTIVITY OF VARIOUS PLANTS EXTRACTS
Chapter 22.2 : Radioactive Decay
Antimicrobials ppt copy
Gene therapy - a Powerpoint Presentation
Gene therapy
Thin layer chromatography
Gene therapy
RNA- Structure, Types and Functions
Gene therapy ppt
Drug Development Life Cycle
Ad

Similar to Bioactivity-guided Fractionation of Selected Botanticals (20)

ODP
Maqui berry
PPT
Tumour inhibitors from plants final
PPTX
Cancer Fighting Foods
PPTX
Cancer Fighting Foods
PPTX
A Comprehensive Review on Anticancer activity of Different Plant Species
PPT
Breast Cancer Drug Discovery From Ethnomedicinal Plants
PPTX
Herbal anti cancer drugs
PDF
Anticancer phytochemicals of citrus fruits new
PDF
Cancer Webinar+May7
PPTX
New Microsoft PowerPoint Presentation.pptx
PPT
Red Reishi/Wheatgrass/So Easy
PPTX
Cancer Phytotherapy
PPTX
Why the blue is good for you
PPT
Phytonutrients
PDF
11.protective effect of phyllanthus niruri on dmba croton oil mediated carcin...
PDF
Protective effect of phyllanthus niruri on dmba croton oil mediated carcinoge...
PDF
Review: Ajwa date (Phoenix dactylifera)- an emerging plant in pharmacological...
PDF
Cytotoxicity of Blended Versus Single Medicinal Mushroom Extracts on Human Ca...
PPT
2. wheatgrass technical
PPTX
Terpenoids as potential chemopreventive and therapeutic agents in
Maqui berry
Tumour inhibitors from plants final
Cancer Fighting Foods
Cancer Fighting Foods
A Comprehensive Review on Anticancer activity of Different Plant Species
Breast Cancer Drug Discovery From Ethnomedicinal Plants
Herbal anti cancer drugs
Anticancer phytochemicals of citrus fruits new
Cancer Webinar+May7
New Microsoft PowerPoint Presentation.pptx
Red Reishi/Wheatgrass/So Easy
Cancer Phytotherapy
Why the blue is good for you
Phytonutrients
11.protective effect of phyllanthus niruri on dmba croton oil mediated carcin...
Protective effect of phyllanthus niruri on dmba croton oil mediated carcinoge...
Review: Ajwa date (Phoenix dactylifera)- an emerging plant in pharmacological...
Cytotoxicity of Blended Versus Single Medicinal Mushroom Extracts on Human Ca...
2. wheatgrass technical
Terpenoids as potential chemopreventive and therapeutic agents in

Recently uploaded (20)

PPTX
IMAGING EQUIPMENiiiiìiiiiiTpptxeiuueueur
PDF
OSCE SERIES - Set 7 ( Questions & Answers ).pdf
DOCX
PEADIATRICS NOTES.docx lecture notes for medical students
PPT
neurology Member of Royal College of Physicians (MRCP).ppt
PPTX
Neonate anatomy and physiology presentation
PDF
OSCE SERIES ( Questions & Answers ) - Set 3.pdf
PPT
nephrology MRCP - Member of Royal College of Physicians ppt
PDF
Lecture on Anesthesia for ENT surgery 2025pptx.pdf
PDF
Plant-Based Antimicrobials: A New Hope for Treating Diarrhea in HIV Patients...
PPT
Rheumatology Member of Royal College of Physicians.ppt
PPTX
Post Op complications in general surgery
PDF
OSCE Series ( Questions & Answers ) - Set 6.pdf
PDF
OSCE Series Set 1 ( Questions & Answers ).pdf
PPTX
y4d nutrition and diet in pregnancy and postpartum
PPTX
Electrolyte Disturbance in Paediatric - Nitthi.pptx
PPTX
Vaccines and immunization including cold chain , Open vial policy.pptx
PPTX
Effects of lipid metabolism 22 asfelagi.pptx
PDF
SEMEN PREPARATION TECHNIGUES FOR INTRAUTERINE INSEMINATION.pdf
PPTX
Human Reproduction: Anatomy, Physiology & Clinical Insights.pptx
PPTX
Reading between the Rings: Imaging in Brain Infections
IMAGING EQUIPMENiiiiìiiiiiTpptxeiuueueur
OSCE SERIES - Set 7 ( Questions & Answers ).pdf
PEADIATRICS NOTES.docx lecture notes for medical students
neurology Member of Royal College of Physicians (MRCP).ppt
Neonate anatomy and physiology presentation
OSCE SERIES ( Questions & Answers ) - Set 3.pdf
nephrology MRCP - Member of Royal College of Physicians ppt
Lecture on Anesthesia for ENT surgery 2025pptx.pdf
Plant-Based Antimicrobials: A New Hope for Treating Diarrhea in HIV Patients...
Rheumatology Member of Royal College of Physicians.ppt
Post Op complications in general surgery
OSCE Series ( Questions & Answers ) - Set 6.pdf
OSCE Series Set 1 ( Questions & Answers ).pdf
y4d nutrition and diet in pregnancy and postpartum
Electrolyte Disturbance in Paediatric - Nitthi.pptx
Vaccines and immunization including cold chain , Open vial policy.pptx
Effects of lipid metabolism 22 asfelagi.pptx
SEMEN PREPARATION TECHNIGUES FOR INTRAUTERINE INSEMINATION.pdf
Human Reproduction: Anatomy, Physiology & Clinical Insights.pptx
Reading between the Rings: Imaging in Brain Infections

Bioactivity-guided Fractionation of Selected Botanticals

  • 1. BIOACTIVITY-GUIDED FRACTIONATION OF SELECTED BOTANICALS 11th International Conference on the Science of Botanicals Oxford, MS April 16-19, 2012 A. Douglas Kinghorn1, Jie Li1, Hee-Byung Chai1, and William J. Keller2 1College of Pharmacy, The Ohio State University and 2Nature’s Sunshine Products, Inc.
  • 2. MR. JIE LI DR. HEE-BYUNG CHAI THE OHIO STATE THE OHIO STATE UNIVERSITY UNIVERSITY DR. WILLIAM J. KELLER NATURE’S SUNSHINE PRODUCTS, INC.
  • 3. OUTLINE OF PRESENTATION  Reminiscences of the Late Norm Farnsworth as a Mentor and Colleague.  Application of “Activity-guided Fractionation” to Furnish Potential Cancer Chemopreventive Principles of Several Botanicals: Black Chokeberry (Aronia melanocarpa), Maqui Berry (Aristotelia chilensis), Mangosteen (Garcinia mangostana), and Noni (Morinda citrifolia).
  • 4. Late Dr. Norman R. Farnsworth University of Illinois at Chicago 1930-2011 (Fong et al., J. Nat. Prod. 69, 311, 2006)
  • 5. SCHOOL OF PHARMACY, UNIVERSITY OF LONDON (THE “SQUARE”; NOW UCL) PROFESSOR JAMES W. FAIRBAIRN (“PROF”) PROFESSOR FRED J. EVANS PROFESSOR J. DAVID PHILLIPSON
  • 7. THE BEST DEPARTMENT OF PHARMACOGNOSY AND PHARMACOLOGY IN THE WORLD, CA. 1977 Shown are the faculty, staff, postdoctorals, and graduate students
  • 8. National Cooperative Drug Discovery Group (NCDDG) (Ohio State, UIC, Research Triangle Institute, Bristol-Myers Squibb, National Cancer Institute) , circa 2005
  • 9. CANCER CHEMOPREVENTION A strategy of cancer control by administration of synthetic or natural compounds to reverse or suppress the process of carcinogenesis (Sporn et al., Fed. Proc., 35, 1332, 1976)
  • 10. SOME PROMISING PLANT-DERIVED COMPOUNDS UNDER DEVELOPMENT BY THE UNITED STATES NATIONAL CANCER INSTITUTE AS POTENTIAL CANCER CHEMOPREVENTIVES Agent(s) Phase Target Cancer(s) Curcumin I/II/III Colon; Pancreatic Genistein II Bladder; Breast; Kidney; Prostate; Skin Indole-3-carbinol I/II/III Breast; Prostate Perillyl alcohol I/II Breast; Leukemia; Pancreatic; Prostate Soy isoflavones II/III Breast; Prostate Tea (green) I/II Bladder; Esophageal; Cervical; Leukemia; Liver; Lung; Prostate Tea/epigallocatechin I Prostate Resveratrol I/II Colon; Solid cancers Vitamin C II Cervical; Ovarian; Uterine Silibinin II Prostate (http://www.clinicaltrials.gov; accessed April, 2008)
  • 11. MAJOR STAGES IN NATURAL PRODUCT DRUG DISCOVERY Organism collection (after development of intellectual property agreements). Preparation of extracts (using standardized extraction scheme). Initial bioassays (cell-based and target-based). Biostatistics; data management; dereplication of leads; lead prioritization). Bioactivity-directed fractionation (= isolation of active compounds from biomass using a decision tree based solely on bioactivity). Structure elucidation of bioactive compounds. Scale up and analog development of lead compounds. Advanced bioassays; data management; biostatistics. Lead optimization; pharmaceutical development. (Clark, In Foye’s Principles of Medicinal Chemisry, 5th Edn., Williams, D.A.; Lemke, T.L., Eds., Lippincott Williams & Wilkins: Baltimore, 2002, p. 24)
  • 12. TYPES OF ASSAYS USED FOR POTENTIAL NATURAL PRODUCT CANCER CHEMOPREVENTIVE AGENTS  SHORT-TERM IN VITRO BIOASSAYS BASED ON FACTORS ASSOCIATED WITH TUMOR INITIATION, PROMOTION AND PROGRESSION Antimutagenicity Tumor Initiation: Antioxidant acitivity Phase II enzyme induction (quinone reductase induction) Antioxidant activity Tumor Promotion: Cyclooxygenase inhibition Aromatase inhibition Ornithine decarboxylase inhibition Aromatase inhibition Tumor Progression: Antiestrogenic activity Receptor assays with luciferase Differentiation-inducing agents (Modified from Pezzuto et al., In Cancer Chemoprevention, Vol. 2: Strategies for Cancer Chemoprevention, G. Kelloff et al., eds., Humana Press, Inc., Totowa, NJ, 2005; p. 3)
  • 13. BLACK CHOKEBERRY (ARONIA MELANOCARPA) (ROSACEAE)  A deciduous shrub originating from the eastern parts of North America and East Canada, which has been introduced to Europe.  Has a long tradition of use in European and North American folk medicine. Now used for the production of jam, juice, tea, wine, and as a natural colorant.  Consumed in part because of its high antioxidant capacity when compared to other berries and fruits. (Kulling et al., Planta Med., 74, 1625, 2008; Valcheva-Kuzmanova et al., Folia Med., 48, 11, 2006) www.vitarroz.com www.seedman.com/fruit.htm
  • 14. BIOLOGICAL ACTIVITIES OF BLACK CHOKEBERRY CONSTITUENTS OR EXTRACTS  Antioxidant activities (phenolics)  Chemopreventive potential via antimutagenic activity, immunomodulatory activity, and inhibition of carcinogenesis and cancer cell proliferation (flavonoid-rich fruit extract, isolated anthocyanins)  Anti-inflammatory activities in vitro and in rats (fruit extract or juice)  Miscellaneous: hepatoprotective, gastroprotective, and cardioprotective effects; antibacterial and antiviral effects; and antidiabetic effects Key references: (Oszmianski et al., Eur. Food Res. Technol., 221, 809, 2005; Sueiro et al., J. Food Sci., 71, C480, 2006; Ding et al., J. Biol. Chem., 281, 17359, 2006; Zapolska-Downar et al., Eur. J. Nutr., DOI: 10.1007/s00394-011-0240-1; Borissova et al., Acta Physiol. Pharmacol. Bulg., 20, 25, 1994; Valcheva-Kuzmanova et al., Exp. Toxicol. Pathol., 56, 195, 2004; Simeonov et al., Folia Med., 44, 20, 2002)
  • 15. HYDROXYL RADICAL-SCAVENGING AND QUINONE REDUCTASE INDUCTION ACTIVITIES OF ISOLATES OF BLACK CHOKEBERRY FRUITS  From the results obtained, the following four isolates (hyperoside, 1; neochlorogenic acid methyl ester, 4; quercetin, 9; protocatechuic acid, 14) showed potent activities in the .OH-scavenging and QR induction assays:
  • 16. MAQUI BERRY (ARISTOTELIA CHILENSIS) (ELAEOCARPACEAE)  A native South America evergreen shrub.  This species produces small edible purple or black berries that are eaten fresh or used for juice, jams, and wine- making. www.healthytastychow.com  The leaves and fruits are astringent and have been used in Chilean folk medicine as anti-diarrheal, anti- inflammatory, antihamorrhagic, and as a febrifuge. (Schreckinger et al., J. Med. Food, 13, 233, 2010; Escribano-Bailon et al., www.vitarroz.com Phytochem. www.seedman.com/fruit.htm http://superberries.co.uk Anal., 17, 8, 2006)
  • 17. BIOLOGICAL ACTIVITIES OF MAQUI BERRY CONSTITUENTS OR EXTRACTS  Antioxidant activities (fruit extract or juice, phenolic extract, and 3-hydroxyindole derivatives)  Chemopreventive effects and induction of apoptosis in cancer cell lines (cyanidin 3-O-glucoside, delphinidin 3-O- glucoside and other anthocyanins, and gallic acid)  Anti-inflammatory activities (leaf extract)  Miscellaneous: analgesic, cardioprotective, α- glucosidase/α-amylase inhibitory, nematicidal, and antiviral activities. Key references: (Cespedes et al., Food Chem., 107, 820, 2008; Cespedes et al., Z. Naturforsch., 64c, 759, 2009; Munoz et al., J. Pharm. Pharmacol., 63, 849, 2011; Rubilar et al., J. Agric. Food Chem., 59, 1630, 2011; Schreckinger et al., J. Med. Food, 13, 233, 2010; Ohno et al., Anti-cancer Drugs, 10, 845, 1999; Hou et al., Curr. Mol. Med., 3, 149, 2003)
  • 18. HYDROXYL RADICAL-SCAVENGING AND QUINONE REDUCTASE INDUCTION ACTIVITIES OF ISOLATES OF MAQUI BERRY  From the results obtained, twelve compounds (1-12) showed potent antioxidant activity in the .OH-scavenging assay. Five compounds (3, 7, 9, 11, and 14) exhibited relatively high QR-inducing activity. Compounds 3 (gallic acid methyl ester), 9 (protocatechuic acid), 7 (hyperoside), and 11 (guaijaverin) are shown below:
  • 19. GARCINIA MANGOSTANA L. (MANGOSTEEN) (CLUSIACEAE)  Garcinia mangostana L. (Clusiaceae), commonly known as “Mangosteen”, is one of the most widely recognized tropical fruits.  Known as the “queen of fruits” and used in Southeast Asian traditional medicine.  In Thai folk medicine, the pericarp of Mangosteen has been used for many years to healing skin infections and wounds and for relief of diarrhea.
  • 20. MANGOSTEEN AS A BOTANICAL DIETARY SUPPLEMENT  Now one of top-selling botanical dietary supplements in the U.S., sales of over $200 million in 2008 (Sloan, Nutraceutical World, 13, 16, 2010).  Mangosteen is used as a constituent of products sold in the United States for its antioxidant effects.  Botanical products are standardized against α- mangostin (ca. 1% w/w yield from pericarps) and -mangostin (ca. 0.25% w/w yield from pericarps).  Quite large amounts of the xanthone α- mangostin may be ingested in mangosteen juice.
  • 21. CHEMICAL CONSTITUENT PROFILE OF GARCINIA MANGOSTANA  The following compound classes have been reported to occur in various plant parts of mangosteen, as published by the end of 2007: Xanthones 68 Flavonoids 5 Benzophenones 3 Triterpenoids and Sterols 7 Miscellaneous 3 (Chin and Kinghorn, Mini-Rev. Org. Chem., 5, 355, 2008)
  • 22. SUMMARY OF BIOLOGICAL ACTIVITIES OF MANGOSTEEN CONSTITUENTS/EXTRACTS  Antioxidant (especially potent are -mangostin and -mangostin)  Infectious disease related Antibacterial Antifungal Antimalarial HIV-protease and reverse transcriptase inhibition  Cancer related Aromatase inhibition (-mangostin is active in both a microsomal and a cell-based assay) Cytotoxicity for cancer cells Inhibition of sphingomyelinase Inhibition of topoisomerases In vivo cancer chemoprevention  Inflammation related Inhibition of COX, iNOS, IKK; in vivo carageenan-induced paw  Miscellaneous Ca2+ATP-ase inhibitor H1-receptor antagonist (Balunas et al., J. Nat. Prod., 71, 1161, 2008; Chin and Kinghorn, Mini-Rev. Org. Chem., 5, 355, 2008)
  • 23. XANTHONES ISOLATED FROM THE PERICARP OF MANGOSTEEN
  • 24. PEROXYNITRITE ANTIOXIDANT ACTIVITY OF ISOLATED XANTHONES IC50 (M)a Compound Authentic ONOO SIN-1 derived ONOO 1* (new) 4.6 10.0 3 (smeathxanthone) 2.2 9.7 4 (-mangostin) 12.2 <0.5 5 (-mangostin) 8.0 3.1 6 (8-deoxygartanin) N.A.c 11.9 7 (gartanin) 9.1 9.3 8 (mangostinone) N.A. N.A. 9 (tovophyllin A) N.A. N.A. 10 (cudraxanthone G) N.A. 3.2 DL-penicillamineb 3.1 7.4 aONOO is the scavenging activity of authentic peroxynitrite and generated peroxynitrite from SIN-1 (IC50: M). Values of ONOO scavenging/inhibitory activities expressed as the mean of three experiments. bDL-Penicillamine used as positive control. cN.A.: no activity within the tested concentration (5-100 M). (Jung et al., J. Agric. Food Chem., 54, 2077, 2006)
  • 25. PHARMACOKINETICS OF PURE -MANGOSTIN AFTER INTRAVENOUS ADMINISTRATION Parameters Mean SE C0 (ng/ml) 17880 4432 Ke (1/hr) 0.26 0.03 t1/2 (hr) 2.97 0.38 AUC0-6 (ng*hr/ml) 1233 157.1 AUC0-∞ (ng*hr/ml) 1372 140.4 Pharmacokinetic parameters were AUMC0-6 (ng*hr*hr/ml) 791.3 63.84 determined after a single intravenous dose of 2 mg/kg -mangostin in rats (n = AUMC0-∞ (ng*hr*hr/ml) 2335 434.2 8), with data calculated using non- compartmental analysis. Disposition MRT (hr) 1.85 0.39 biphasic (fast distribution; slow Vz (L/kg) 6.82 1.10 elimination).. CL (L/hr/kg) 1.54 0.12 (Li et al., Mol. Nutr. Food Res. 55, S67, 2011)
  • 26. PHARMACOKINETICS OF PURE -MANGOSTIN AFTER ORAL ADMINISTRATION  On oral administration of a single dose of 20 mg/kg -mangostin to rats, the bioavailability was so low (ca. 0.4%) that it was not possible to obtain a full concentration-time profile.  As a result of this study, it was concluded that it is questionable if the in vitro effects of -mangostin occur in an in vivo setting. (Li et al., Mol. Nutr. Food Res. 55, S67, 2011)
  • 27. DETERMINATION OF BIOAVAILABILITY IN HUMANS OF XANTHONES FROM MANGOSTEEN JUICE  The bioavailability of mangosteen xanthones using human subjects has received comparatively little attention.  In a preliminary study, Kondo et al. administered ca. 60 mL of a supplement (mangosteen; aloe vera; green tea; multivitamins) to 20 fasted healthy human volunteers, and it was concluded that -mangostin is bioavailable (observed Cmax at tmax of ca. 1 hour) (Kondo et al. J. Agric. Food Chem., 57, 8788, 2009).  In a study carried out at The Ohio State University, the bioavailability of xanthones was investigated in ten healthy adults (five females; five males), who consumed a single dose of 100% mangosteen juice along with a typical fast- food (high-fat) breakfast, which was supplemented with canola oil and soybean oil (Chitchumroonchokchai et al. J. Nutr., 142, 675, 2012).
  • 28. PROFILE OF XANTHONE CONTENT IN THE MANGOSTEEN JUICE USED IN THE STUDY  When analyzed by Content Percentage of Xanthones in juice total xanthones HPLC, the 100% (µM) identified (%) mangosteen juice garcinone C 291 + 11.2 5.5 used in the study garcinone D 520 + 10.9 10.2 garcinone E 239 + 18.5 5.1 provided 5.3 + 0.1 α-mangostin 3190 + 123 59.9 mM total β-mangostin 121 + 9.3 2.3 xanthones, with α- -mangostin 356 + 4.3 6.5 mangostin being 8-deoxygartanin 176 + 4.5 3.1 the most abundant gartanin 157 + 6.9 2.8 tovophillin B 50 + 2.9 1.1 (59.9%), as 9-hydroxycalabaxanthone 193 + 7.4 3.6 indicated in the Totals 5290 + 166 100 table. Values are means + SD; n = 5 independent replicates (Chitchumroonchokchai et al., J. Nutr., 142, 675, 2012)
  • 29. PHARMACOKINETIC PARAMETERS OF FREE AND CONJUGATED α-MANGOSTIN IN SERUM  There was marked variation Participant AUC (nM/L x h) Cmax (nM/L) Tmax (h) in values of AUC (area under Females the curve, 762-4029 nM x h), 1 1605 78 3 Cmax (maximum 2 962 57 8 concentration, 42-450 nM), 3 4029 450 3 4 1484 132 2 and Tmax (time to the 5 1249 79 3 maximum concentration, 2-8 Mean + SD 1870 + 1230 159 + 165 3.8 + 2.4 h) for α-mangostin in the Males serum, during the 24-h 1 1004 42 2 collection period. 2 771 44 8  The serum AUC, Cmax, and 3 1798 154 4 Tmax values of α-mangostin 4 816 42 2 were similar in female and 5 762 49 2 male participants. Mean + SD 1030 + 440 66 + 49 3.6 + 2.6 (Chitchumroonchokchai et al., J. Nutr., 142, 675, 2012)
  • 30. CONCLUSIONS FROM THE OHIO STATE BIOAVAILABILITY STUDY ON XANTHONES FROM MANGOSTEEN JUICE  Both free and conjugated (glucuronidated/sulfated) xanthones were detected in serum and urine of healthy adult participants.  There was marked variation in the AUC, Cmax, and Tmax for α- mangostin in serum samples during the 24-h collection period.  The total xanthones in the 24-h urine samples ranged from 0.9- 11.2 μM and accounted for ca. 2.0 ± 0.3% (range 0.3-3.4%) of the ingested dose of mangosteen juice.  There were no significant differences between female and male participants in mean pharmacokinetic values of α-mangostin in serum and urinary total xanthones.  Xanthones in mangosteen juice were absorbed when ingested along with a high fat meal, although the release of xanthones from the juice during digestion may be somewhat limited. (Chitchumroonchokchai et al., J. Nutr., 142, 675, 2012)
  • 31. NONI (MORINDA CITRIFOLIA L.) (RUBIACEAE)  Occurs in tropical and subtropical regions http://www.nps.gov/kaho/KAHOckLs/KAHOplnt/noni.htm  Small evergreen tree or shrub  Flowers perfect with five- lobed, small white corollas  5 to 10 cm long fleshy, syncarpous fruit  Unpleasant taste and butyric acid odor when ripe  All parts (fruit, leaf, bark, flower, and seed) have been used medicinally  Roots and bark are used as a dye (Pawlus and Kinghorn, J. Pharm. Pharmacol. 59, 1587, 2007)
  • 32. CHEMICAL CONSTITUENT PROFILE OF MORINDA CITRIFOLIA The following compound classes have been reported to occur in various plant parts of noni, with effect from mid-2007: Anthraquinones 45 Flavonoids 10 Iridoids 18 Lignans 11 Triterpenoids and Sterols 12 Miscellaneous >38 (Pawlus and Kinghorn, J. Pharm. Pharmacol. 59, 1587, 2007)
  • 33. QUINONE REDUCTASE-INDUCING ACTIVITY OF ISOLATED CONSTITUENTS OF NONI FRUITS Compound CDa, M (g/mL) IC50b, M (g/mL) CIc 1d 0.009 (0.0027) >69.9 (>20) >7770 2 1.67 (0.52) >66.6 (>20) >39.9 L-sulforaphane* 0.34 (0.061) 9.77 (1.73) 28.7 aCD = Concentration required to double quinone reductase induction. bIC50 = Concentration for 50% inhibition of cell viability. cCI = Chemopreventive Index. d Only 2 mg of 1,3,6- trihydroxy-2-methoxyanthraquinone(1) isolated from ca. 9 kg dried noni fruits. * = Control. 1 (new) 2 (Pawlus et al., J. Nat. Prod. 68, 1720, 2005)
  • 34. INHIBITORY EFFECT OF NONI FRUITS ON RAT ESOPHAGEAL TUMORIGENESIS  Male F344 rats were fed a diet of 5% w/w dried powdered fruits of M. citrifolia (noni), and six other dried fruits, including black raspberry (Rubus occidentalis), in a comparison study.  The standard carcinogen, NMBA (N- nitrosomethylbenzylamine was used to treat rats for five weeks, and the experiment was terminated after 35 weeks.  All seven fruits had similar effects on reducing esophageal tumor incidence, size, and multiplicity, and also reduced the levels of two serum cytokines.  Noni fruits have lower levels of anthocyanins and ellagitannins than black raspberries. (Stoner et al., Pharm. Res. 27, 1138, 2010)
  • 35. SEARCH FOR BIOLOGICALLY ACTIVE PRINCIPLES OF BOTANICAL DIETARY SUPPLEMENTS: SUMMARY Botanical dietary supplements have become widely available in the United States since the passage of the Dietary Supplement Health and Education Act (DSHEA) in 1994. Their widespread use has had a major impact on biomedical research and pharmacy practice. Fractionation studies on selected “botanicals” have yielded quite potent biologically active compounds, although generally occurring at low concentrations. Some of these are useful leads as potential cancer chemopreventive agents. The fruits of mangosteen (G. mangostana) and noni (M. citrifolia) have already yielded interesting bioactive compounds. The constituents of these botanical dietary supplements seem to offer particular promise for further investigation.
  • 36. ACKNOWLEDGMENTS Phytochemical Studies Biological Testing The Ohio State University The Ohio State University Dr. Young-Won Chin Dr. Marcy P. Balunas Dr. Ye Deng Dr. Young-Won Chin Dr. Hyun-Ah Jung Ms. Chureeporn Chitchumroonchokchai (Human Nutrition) Dr. Alison D. Pawlus Dr. Alison D. Pawlus (at University of Illinois at Dr. Baoning Su Chicago) Dr. Bin Su (Dr. Robert W. Brueggermeier) Collaborators – The Ohio Collaborator – University State University of Florida Dr. Steven Clinton Dr. Veronika Butterweck Dr. Mark Falia Supply of Botanicals Dr. Gary D. Stoner Nature’s Sunshine Products, Inc., Spanish Fork, Utah Faculty start-up funding from the Molecular Carcinogenesis and Chemoprevention Program of The Ohio State University Comprehensive Cancer Center (to A.D. Kinghorn), and an unrestricted gift from Nature’s Sunshine Products, Inc. are gratefully acknowledged.
  • 37. THE PRESCIENT DR. FARNSWORTH!
  • 38. College of Pharmacy and OSU Comprehensive Cancer Center